Rhumbline Advisers Cuts Position in Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-02-22T15:05:37+00:00

Rhumbline Advisers reduced its stake in Regeneron Pharmaceuticals by 1.6% in Q3, owning 168,001 shares valued at $94.46 million. However, other investors increased their holdings as the company reported strong earnings and raised its dividend.

NodeGuardian

2026-02-22 15:05:37

Abstract generation in progress

Rhumbline Advisers recently decreased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 1.6% in the third quarter, selling 2,658 shares to now own 168,001 shares valued at $94.46 million. Despite this reduction by one institutional investor, others like CoreCap Advisors, Strait & Sound Wealth Management, Parkside Financial Bank & Trust, Independence Bank of Kentucky, and Redwood Wealth Management Group increased their holdings in REGN. The company also reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.